And while none of the funding was for domestic health care programs, the passage of the so-called rescissions package could ...

Researchers call for reform after a new study found U.S. preeclampsia guidelines lead to a high rate of false positives.

In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...

Cola, how Medicaid data will be used to track immigrants, and how overdose deaths could rise with the GOP tax law.

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

Robert F. Kennedy Jr. just named Mark Cruz, a Klamath member, his top tribal health adviser. In a Q&A, Cruz emphasized tribal ...

Losing access to addiction medications doubles overdose risk. A new analysis says projected Medicaid cuts could add 1,000 ...

Many of the 17 million projected to lose Medicaid coverage will turn to struggling free health clinics. They need more ...

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to ...

Today, senators uncover details about pharma deals with telehealth companies. Plus: More Medicare tech updates and a look at the drama between FDA and Whoop.

President Trump was checked for swelling in his legs and was diagnosed with chronic venous insufficiency, a common condition in older adults.

Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...